Hanan Aljedani

Hanan Aljedani

Auto-generated profile, based on publicly available information

Hanan Aljedani

College of Medicine King Saud Bin Abdulaziz University for Health Sciences Jeddah Saudi Arabia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2025 in Clinical Genetics
Verified
Journal Article
Closed access
ASAiman Shawli
Aiman Shawli
HAHanan Aljedani
Hanan Aljedani
JMJomanah Mazi
Jomanah Mazi
DFDalia Felemban
Dalia Felemban
SASarah Aljemaey
Sarah Aljemaey

28 January 2025 in Cureus
Verified
Journal Article
Open access
PDF file
LBLina Bazeeb
Lina Bazeeb
HAHanan A Aljedani
Hanan A Aljedani
MAManar S. Alghamdi
Manar S. Alghamdi
BJBayan Jamjoom
Bayan Jamjoom
ASAiman M. Shawli
Aiman M. Shawli
A substantial loss in the 12q24.23q24.31 area has been associated with neurodevelopmental abnormalities, intellectual difficulties, and developmental delays. There are several chromosomal deletion syndromes worldwide, each with its own set of features. However, the rarity of this deletion in 12q24.23q24.31 presents an opportunity to expand the existing knowledge on this topic. Our case involved a seven-year-old girl with no history of consanguinity, who was discovered to have a 6.6 Mb deletion in the 12q24.23q24.31 region. She was diagnosed with refractory epilepsy, spasticity in all limbs, and global developmental delay with intellectual disabilities. She was able to do basic movements with assistance, identify familiar people, and respond to simple instructions. Some significant physical traits included widely separated eyes, a small nasal tip, and congenital heart defects, such as tricuspid atresia and a single ventricle heart. She also demonstrated clubbing in her fingers and toes, as well as toe overlapping. The purpose of this case report is to contribute to our understanding of deletions in the 12q24.23q24.31 chromosomal region and their clinical implications.

1 January 2025 in International Journal of Endocrinology
Verified
Journal Article
Open access
HAHanan Aljedani
Hanan Aljedani
JMJomanah Mazi
Jomanah Mazi
AAArwa Almutairi
Arwa Almutairi
HNHalah Namnkani
Halah Namnkani
RAReffal Aldainiy
Reffal Aldainiy
AAAlaa Althubaiti
Alaa Althubaiti
Background: Diabetes mellitus (DM) is a growing concern globally. DM control is indicated by hemoglobin A1c, measuring glucose levels within two to 3 months. Patients with DM who have surgery may experience postoperative hyperglycemia (POHG) which is associated with many complications. This study aimed to investigate POHG incidence among patients with DM based on their level of glycemic control. Methods: This was a retrospective cohort study of patients with DM ≥ 18 years who had orthopedic, intra‐abdominal, cardiothoracic, or vascular surgery at King Abdulaziz Medical City, Jeddah, between October 2016 and October 2023. Patients with DM were considered controlled if the hemoglobin A1c was < 7%. Results: The study included 306 patients, and the majority (69.28%) experienced POHG. There was a significant association between POHG and the level of glycemic control. POHG was experienced by 32.55% of patients with controlled DM vs 67.45% of patients with uncontrolled DM. Furthermore, patients with preoperative random glucose readings (RBG) of ≥ 9.2 mmol/L had a significantly higher risk of developing POHG. Moreover, older age and male sex were associated with higher POHG risk. Conclusion: Our data indicate that the incidence of POHG was significantly greater among patients with uncontrolled DM. Patients with DM with a preoperative RBG of ≥ 9.2 mmol/L had a higher likelihood of developing POHG. Future research should include a larger sample and investigate associations between POHG, other complications, and the influence of varying levels of DM control.

6 November 2025 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
HAHanan Aljedani
Hanan Aljedani
YFYousef Faden
Yousef Faden
MAManar Alghamdi
Manar Alghamdi
AAAlshaimaa Alzahrani
Alshaimaa Alzahrani
ASAiman Shawli
Aiman Shawli
RAReem Albakistani
Reem Albakistani
Chromosomal deletion syndromes are common worldwide. However, one rare condition that distinguishes a limited number of reported cases and variable phenotypes is 20p12.3 microdeletion syndrome. This case report describes a nine-year-old girl diagnosed with 20p12.3 microdeletion syndrome. Genetic testing revealed a deletion spanning 3.5 Mb and containing 31 genes. The patient presented with a range of clinical manifestations, including growth faltering, short stature, controlled seizure disorder, dysmorphic features, and metabolic disturbances. Regarding dysmorphic features, she presented with malar hypoplasia, a high arched palate, microstomia, long philtrum, proptosis, and retrognathia. Metabolic disturbances were primarily manifested as episodes of hypoglycemia with a high anion gap metabolic acidosis. Despite receiving growth hormone therapy as management for short stature, the patient exhibited low levels of insulin-like growth factor 1 (IGF1). This case report adds to the limited body of knowledge regarding 20p12.3 microdeletion syndrome.

14 October 2026 in European Spine Journal
Verified
Journal Article
Open access
PDF file
AAAbdulrahim Saleh Alrasheed
Abdulrahim Saleh Alrasheed
HAHanan Aljedani
Hanan Aljedani
FNFatma Esam Nasraldin
Fatma Esam Nasraldin
ABAbdulmalek Mamdouh Baajajah
Abdulmalek Mamdouh Baajajah
LJLina A. Justenia
Lina A. Justenia
FAFaisal Rashed AlMatrafi
Faisal Rashed AlMatrafi
Purpose Postoperative voiding dysfunction (POVD) is a significant complication of spinal dysraphism and lumbosacral spinal tumor resection. Conventional intraoperative neurophysiological monitoring modalities primarily assess the descending motor pathway and may not fully evaluate the integrity of the sacral reflex pathway. Intraoperative bulbocavernosus reflex (BCR) monitoring provides a real-time assessment of the sacral reflex arc’s afferent and efferent pathways and may predict postoperative urinary function. However, its diagnostic performance and clinical utility remain incompletely defined. Therefore, this study aimed to evaluate the predictive value and diagnostic accuracy of intraoperative BCR monitoring for POVD in patients undergoing lumbosacral spine surgery. Methods PubMed, Medline, Scopus, and Web of Science were searched comprehensively through March 2026. Random-effects models were used to pool BCR feasibility, diagnostic performance (sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV)), and the association between end-of-surgery BCR status and POVD. Leave-one-out sensitivity analyses and meta-regression were conducted to explore potential sources of heterogeneity. Results Intraoperative BCR monitoring was feasible with a success rate of 94%. BCR demonstrated moderate sensitivity of 62% (95% CI: 0.38–0.81) and high specificity of 99% (95% CI: 0.95–1.00) for predicting POVD. The pooled PPV, NPV, and accuracy were 93% (95% CI: 0.63–0.99), 94% (CI: 0.88–0.97), and 93% (CI: 0.87–0.96), respectively. End-of-surgery BCR maintenance was significantly associated with lower likelihood of POVD (OR: 0.02; 95% CI: 0.00–0.32; P = 0.0019). Conversely, BCR disappearance showed an imprecise trend towards higher likelihood of POVD (OR: 6.91; 95% CI: 0.87- 54.85; P = 0.0642). Conclusion Intraoperative BCR monitoring is feasible and may provide clinically useful predictive information for POVD after lumbosacral spine surgery. Its high specificity and NPV support its use as a part of a multimodal neuromonitoring protocol for assessing sacral pathway integrity. Further prospective studies are needed to validate its predictive performance and standardize monitoring protocols and outcome definitions.